Revenue by quarter

These are our most recent published revenue figures.

(DKKm)	Q1 2008	Q1 2007
Europe
Cipralex®	823	673
Ebixa®	375	317
Azilect®	50	32
Serdolect®	7	7
Other pharmaceuticals	262	304
Total revenue, Europe	1,516	1,334

US**
Income from Lexapro®	661	628
Other pharmaceuticals	-	4
Total revenue, US	661	631

International Markets***
Cipralex®	393	317
Ebixa®	82	74
Azilect®	5	2
Serdolect®	5	2
Other pharmaceuticals	166	157
Total revenue, International Markets	651	552
Other revenue	54	65
Total group revenue	2,882	2,583

Read also